DPI-386 nasal gel
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DPI-386 nasal gel, covering 2019-04-19 to 2020-01-07. Get the full timeline:
Most recent: Clinical Trial Update: DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness [Phase 2, Phase 3]